IR
PFE icon

Invictus RG’s Pfizer PFE Stock Holding History

Invictus RG’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-632
Closed -$21K – 438
2017
Q3 		$21K Buy
632
+242
+62% +$7.78K 0.02% 445
2017
Q2 		$12K Sell
390
-79
-17% -$2.49K 0.01% 549
2017
Q1 		$15K Buy
469
+28
+6% +$883 0.01% 643
2016
Q4 		$14K Buy
+441
New +$13.5K 0.01% 576
2016
Q3 		– Sell
-6,664
Closed -$223K – 766
2016
Q2 		$223K Buy
+6,664
New +$213K 0.24% 164

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invictus RG's PFE Position: Q4 2017 in Review

Invictus RG sold out of Pfizer (PFE) in Q4 2017, closing a stake of 632 shares — an estimated $21K sold.

Invictus RG first reported a position in PFE in Q2 2016 and held it in 5 quarters. The position peaked at $223K in Q2 2016. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Invictus RG reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Invictus RG sold 632 Pfizer shares in Q4 2017, an estimated $21K.
  • Invictus RG first reported a position in Pfizer in Q2 2016 and held it in 5 quarters.
  • Invictus RG's Pfizer position peaked at $223K in Q2 2016.
  • 2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Invictus RG's 13F filing for Q4 2017, filed 13 Feb 2018.